Mission Statement Physicians dedicated to improving the treatment of substance use disorders. A State chapter of the American Society of Addiction Medicine.

Evidence-Based Marijuana Information

As physicians dedicated to improving the treatment of substance use disorders, the California Society of Addiction Medicine (CSAM) provides the voice of addiction medicine specialists on clinical issues and public policy in California. CSAM as pulled together evidence-based information on cannabis that can inform discussion of cannabis with good scientific evidence and social justice. [Evidence-Based Cannabis Information]

CSAM Releases Results of Survey on Insurance Barriers to Medication-Assisted Treatment of Opioid Use Disorders 

The California Society of Addiction Medicine (CSAM) conducted a statewide survey during the September 2016 to assess insurance barriers in California to the treatment of patients with opioid use disorders. A report, authored by David Kan, MD, CSAM President-Elect and Chair of the Committee on Opioids, and approved by the CSAM Executive Council is being circulated to insurance providers and policy makers in California.

This survey documented that insurance-imposed barriers to medically-assisted treatment of opioid dependence continue to exist. Among the survey's findings: 62% of physicians whose patients have insurance coverage find it difficult to access medication-assisted treatment (MAT); 46% experience barriers to maintenance treatment, 47% are unable to prescribe, due to coverage limits, the formulations that they believe are best for the patient, and 35% experience difficulty prescribing the dose needed by their patient.

Read the Report

Continuing Medical Education

Now Online: Essentials of Addiction Medicine 2016

The Essentials of Addiction Medicine Conference provides an in-depth overview of what really is essential in treating addicted patients: from basic epidemiology, pharmacology, and neurobiology, to the challenge of identifying dependent or at-risk patients across many different treatment settings, from the emergency room to the intensive care unit to private practice. Participants will come away with practical knowledge that can be applied to real-world experiences, as well as the knowledge needed to pass the ABMS addiction medicine board exam in the future.


Watch a sample presentation: Addiction in Pregnancy | Mishka Trepan, MD, MPH
45 minutes | Video only (no CME)

Save the date!
Addiction Medicine State of the Art 2017

August 24 - August 27, 2017 (corrected dates)
Hilton San Francisco Union Square

Public Policy

CSAM Cannabis Policy Statements

An initiative to legalize cannabis will appear on the 2016 California ballot. In the advent of policy changes that may increase availability of cannabis, an addictive drug, what are credible and evidence-based positions that prevent addiction, prevent harm to vulnerable populations, and promote access to quality treatment? CSAM believes that it is not necessary to support an initiative to work toward ensuring that whatever initiative is presented or eventually adopted takes measures to mitigate public health harms associated with expanded access to and use of cannabis.

  • CSAM has established recommendations for cannabis policy in the prospect of possible ballot initiatives legalizing cannabis in California. [Read CSAM recommendations]
  • The Control, Regulate and Tax Adult Use of Marijuana Act (Initiative No. 15-0103) is one of several initiatives seeking a place on the 2016 ballot.  CSAM has submitted comments to the initiative's drafters through the California Attorney General's Office. [Read CSAM comments]  

Governor Brown Approves Statewide Program for Early Identification and Treatment of Physicians

For the past seven years, California has lacked a coordinated statewide program for early intervention and treatment of physicians who are developing problems with alcohol and drugs. Now, thanks to legislation authored by Senator Cathleen Galgiani and signed by Governor Jerry Brown, a program will be created to initiate referral of those physicians to treatment and to monitor those physicians until it can be assured that they may safely resume medical practice. [read full press release]